Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study : The Lancet Neurology
Links shared publicly online about this topic.
- 278total visits
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study : The Lancet Neurology
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. By - Dr Bhupendra Khatri MD, Frederik Barkhof MD, Giancar...
View full resource at thelancet.com
Tags: Neurology, Multiple Sclerosis, Multiple Sclerosis Medication, Avonex, Rebif
Most Recently Shared on May 21, 2011 at 3:12 am By:
[Articles] Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomi... http://bit.ly/lLRSIf
Neurology Article | Multiple Sclerosis
mdlinx.com — “Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study” View full resource at mdlinx.com
Most Recently Shared on May 23, 2011 at 4:56 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised ... http://bit.ly/jOjkOQ #neuro
Advertisement
